Back
Staar Surgical Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
68
STAA
Staar Surgical
Last Price:
46.32
Seasonality Move:
13.84%
Sell
7
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-9.04%
Buy
68
Staar Surgical (STAA)
is a Buy
Is Staar Surgical a Buy, Sell or Hold?
- The current Staar Surgical [STAA] share price is $46.58. The Score for STAA is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- STAA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
7
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
STAA Stock Price Chart
What is Staar Surgical's stock price today?
-
The Staar Surgical share price today is $46.58
The current trend is moderately bullish and STAA is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
STAA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.63 | Buy |
| Relative Strength Index (14 RSI): | 60.41 | Buy |
| Chaikin Money Flow: | 54256 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.64 - 47.52) | Buy |
| Bollinger Bands (100): | (28.53 - 39.75) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 23.8 | Sell |
| Chaikin Money Flow: | 1016959 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.09 - 0.13) | Sell |
| Bollinger Bands (100): | (0.12 - 0.24) | Sell |
STAA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.46 | Sell |
| 20-day SMA: | 43.11 | Buy |
| 50-day SMA: | 37 | Buy |
| 200-day SMA: | 39.04 | Buy |
| 8-day EMA: | 47.54 | Sell |
| 20-day EMA: | 44.19 | Buy |
| 50-day EMA: | 39.29 | Buy |
| 200-day EMA: | 40.99 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Sell |
| 20-day SMA: | 0.11 | Sell |
| 50-day SMA: | 0.13 | Sell |
| 200-day SMA: | 0.36 | Sell |
| 8-day EMA: | 0.09 | Sell |
| 20-day EMA: | 0.1 | Sell |
| 50-day EMA: | 0.13 | Sell |
| 200-day EMA: | 0.61 | Sell |
Staar Surgical Earnings Growth & STAA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.42 per share, and an increase next year of $0.39 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Staar Surgical Technical Analysis
| Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||